Use of hypnotic drugs among Scandinavian children, adolescents, and young adults

Introduction Hypnotic drug use in children and adolescents is widely debated. Objectives To describe use of hypnotic drugs (melatonin, z-drugs and sedating antihistamines) among 5-24-year-old Scandinavians during 2012 to 2018. Methods Aggregate-level data from public data sources in Sweden, Norwa...

Full description

Bibliographic Details
Main Authors: R. Wesselhøft, L. Rasmussen, P. Jensen, P. Jennum, S. Skurtveit, I. Hartz, J. Reutfors, P. Damkier, M. Bliddal, A. Pottegård
Format: Article
Language:English
Published: Cambridge University Press 2022-06-01
Series:European Psychiatry
Subjects:
Online Access:https://www.cambridge.org/core/product/identifier/S0924933822002504/type/journal_article
_version_ 1797616221255892992
author R. Wesselhøft
L. Rasmussen
P. Jensen
P. Jennum
S. Skurtveit
I. Hartz
J. Reutfors
P. Damkier
M. Bliddal
A. Pottegård
author_facet R. Wesselhøft
L. Rasmussen
P. Jensen
P. Jennum
S. Skurtveit
I. Hartz
J. Reutfors
P. Damkier
M. Bliddal
A. Pottegård
author_sort R. Wesselhøft
collection DOAJ
description Introduction Hypnotic drug use in children and adolescents is widely debated. Objectives To describe use of hypnotic drugs (melatonin, z-drugs and sedating antihistamines) among 5-24-year-old Scandinavians during 2012 to 2018. Methods Aggregate-level data from public data sources in Sweden, Norway and Denmark. We calculated annual prevalence (users/1000 inhabitants) stratified by sex, age group and country. Quantity of use (Defined Daily Dose (DDD)/user/day) was estimated for Norway and Denmark. Results Melatonin was most frequently used, with an increase from 2012 to 2018 in all countries. Sweden presented the highest rise (7 to 25/1,000) compared to Denmark (6 to 12/1,000) and Norway (10 to 20/1,000). The increase was strongest for females and 15-24-year-olds. Melatonin use was twice as common for males under age 15 years, and slightly more common for females thereafter. The annual prevalence of sedating antihistamine use doubled from 7 to 13/1,000 in Sweden, whereas it was more stable in Norway and Denmark, reaching 8/1,000 and 3/1,000, respectively. Z-drug use decreased in all countries, lowering to 4/1,000 in Sweden and Norway in 2018 and 2/1,000 in Denmark. The quantity of hypnotic use in Norway and Denmark was 1 DDD/user/day for melatonin, as compared to 0.1-0.3 for z-drugs and antihistamines. Conclusions There is an increasing use of melatonin and sedating antihistamines among Scandinavian children, adolescents and young adults. The increase is more pronounced in Sweden compared to Norway and Denmark. This Scandinavian discrepancy could reflect variation in frequency of sleep problems or national variation in clinical practice or health care access. Disclosure No significant relationships.
first_indexed 2024-03-11T07:37:15Z
format Article
id doaj.art-a37d3311270e4fbea2e8946246a96e6a
institution Directory Open Access Journal
issn 0924-9338
1778-3585
language English
last_indexed 2024-03-11T07:37:15Z
publishDate 2022-06-01
publisher Cambridge University Press
record_format Article
series European Psychiatry
spelling doaj.art-a37d3311270e4fbea2e8946246a96e6a2023-11-17T05:09:14ZengCambridge University PressEuropean Psychiatry0924-93381778-35852022-06-0165S82S8310.1192/j.eurpsy.2022.250Use of hypnotic drugs among Scandinavian children, adolescents, and young adultsR. Wesselhøft0L. Rasmussen1P. Jensen2P. Jennum3S. Skurtveit4I. Hartz5J. Reutfors6P. Damkier7M. Bliddal8A. Pottegård9Mental Health Services in the Region of Southern Denmark, Child And Adolescent Psychiatry Odense, Odense C, DenmarkClinical Pharmacology, Pharmacy and Environmental Medicine, Institute Of Public Health, Odense C, DenmarkClinical Pharmacology, Pharmacy and Environmental Medicine, Institute Of Public Health, Odense C, DenmarkDanish Center for Sleep Medicine, Rigshospitalet, Copenhagen University, Copenhagen N, DenmarkNorwegian Institute of Public Health, Department Of Mental Disorders, Oslo, NorwayNorwegian Institute of Public Health, Department Of Mental Disorders, Oslo, NorwayKarolinska Institutet, Medicine Solna, Stockholm, SwedenOdense University Hospital, Dept. Of Clinical Biochemistry And Pharmacology, Odense C, DenmarkClinical Pharmacology, Pharmacy and Environmental Medicine, Institute Of Public Health, Odense C, DenmarkClinical Pharmacology, Pharmacy and Environmental Medicine, Institute Of Public Health, Odense C, Denmark Introduction Hypnotic drug use in children and adolescents is widely debated. Objectives To describe use of hypnotic drugs (melatonin, z-drugs and sedating antihistamines) among 5-24-year-old Scandinavians during 2012 to 2018. Methods Aggregate-level data from public data sources in Sweden, Norway and Denmark. We calculated annual prevalence (users/1000 inhabitants) stratified by sex, age group and country. Quantity of use (Defined Daily Dose (DDD)/user/day) was estimated for Norway and Denmark. Results Melatonin was most frequently used, with an increase from 2012 to 2018 in all countries. Sweden presented the highest rise (7 to 25/1,000) compared to Denmark (6 to 12/1,000) and Norway (10 to 20/1,000). The increase was strongest for females and 15-24-year-olds. Melatonin use was twice as common for males under age 15 years, and slightly more common for females thereafter. The annual prevalence of sedating antihistamine use doubled from 7 to 13/1,000 in Sweden, whereas it was more stable in Norway and Denmark, reaching 8/1,000 and 3/1,000, respectively. Z-drug use decreased in all countries, lowering to 4/1,000 in Sweden and Norway in 2018 and 2/1,000 in Denmark. The quantity of hypnotic use in Norway and Denmark was 1 DDD/user/day for melatonin, as compared to 0.1-0.3 for z-drugs and antihistamines. Conclusions There is an increasing use of melatonin and sedating antihistamines among Scandinavian children, adolescents and young adults. The increase is more pronounced in Sweden compared to Norway and Denmark. This Scandinavian discrepancy could reflect variation in frequency of sleep problems or national variation in clinical practice or health care access. Disclosure No significant relationships. https://www.cambridge.org/core/product/identifier/S0924933822002504/type/journal_articlepharmacoepidemiologyChild and adolescentmelatonindrug utilisation
spellingShingle R. Wesselhøft
L. Rasmussen
P. Jensen
P. Jennum
S. Skurtveit
I. Hartz
J. Reutfors
P. Damkier
M. Bliddal
A. Pottegård
Use of hypnotic drugs among Scandinavian children, adolescents, and young adults
European Psychiatry
pharmacoepidemiology
Child and adolescent
melatonin
drug utilisation
title Use of hypnotic drugs among Scandinavian children, adolescents, and young adults
title_full Use of hypnotic drugs among Scandinavian children, adolescents, and young adults
title_fullStr Use of hypnotic drugs among Scandinavian children, adolescents, and young adults
title_full_unstemmed Use of hypnotic drugs among Scandinavian children, adolescents, and young adults
title_short Use of hypnotic drugs among Scandinavian children, adolescents, and young adults
title_sort use of hypnotic drugs among scandinavian children adolescents and young adults
topic pharmacoepidemiology
Child and adolescent
melatonin
drug utilisation
url https://www.cambridge.org/core/product/identifier/S0924933822002504/type/journal_article
work_keys_str_mv AT rwesselhøft useofhypnoticdrugsamongscandinavianchildrenadolescentsandyoungadults
AT lrasmussen useofhypnoticdrugsamongscandinavianchildrenadolescentsandyoungadults
AT pjensen useofhypnoticdrugsamongscandinavianchildrenadolescentsandyoungadults
AT pjennum useofhypnoticdrugsamongscandinavianchildrenadolescentsandyoungadults
AT sskurtveit useofhypnoticdrugsamongscandinavianchildrenadolescentsandyoungadults
AT ihartz useofhypnoticdrugsamongscandinavianchildrenadolescentsandyoungadults
AT jreutfors useofhypnoticdrugsamongscandinavianchildrenadolescentsandyoungadults
AT pdamkier useofhypnoticdrugsamongscandinavianchildrenadolescentsandyoungadults
AT mbliddal useofhypnoticdrugsamongscandinavianchildrenadolescentsandyoungadults
AT apottegard useofhypnoticdrugsamongscandinavianchildrenadolescentsandyoungadults